Log in to MyACC
Coronary Angioplasty Versus Excisional Atherectomy Trial II - CAVEAT II
Description:
Directional atherectomy vs. PTCA for adverse event in patients with SVGs.
Hypothesis:
To compare directional atherectomy with balloon angioplasty in saphenous vein grafts.
Study Design
Study Design:
Patients Screened: Not given
Patients Enrolled: 305
Patient Populations:
De novo saphenous vein graft lesions
Significant stenosis between 60-100%
Suitable for either PTCA or DCA
Primary Endpoints:
Repeat procedures
Secondary Endpoints:
Angiographic restenosis
Drug/Procedures Used:
Directional atherectomy (DCA) vs. balloon angioplasty (PTCA)
Concomitant Medications:
Aspirin, heparin, calcium channel blockade
Principal Findings:
Initial procedural success higher for DCA (89.2%) compared to PTCA (79.0%), with larger luminal gains (1.45mm vs 1.12mm).
Early complications were more frequent with DCA. Distal embolization was significantly higher (p = 0.012) for the DCA group (13.4%) compared to the PTCA group (5.1%). Rates of non-Q wave MI were also higher for the DCA group (16.1% vs 9.6%), although this trend was not statistically significant.
At six months, there was no significant difference in the need for repeat procedures (13.2% DCA vs 22.4% PTCA) or in restenosis rates (45.6% DCA vs 50.5% PTCA).
Interpretation:
As in CAVEAT I, directional atherectomy was associated with higher initial complication rates, with no significant long-term clinical benefit over angioplasty.
References:
1. Circulation 1995;91:1966-74. Final results
Keywords: Myocardial Infarction, Atherectomy, Coronary, Saphenous Vein, Coronary Disease, Constriction, Pathologic, Angioplasty, Balloon, Coronary
< Back to Listings
